Videos / An update on semaglutide for CKD in the presence of T2D
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

GLP 1s & Sarcopenia: Fact vs Hype

The New Dengue Vaccine – What You Need to Know

Hypertriglyceridaemia – Causes, Assessment & Management of CV Risk

Management of Photoageing

expert
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne